Home > News > Intel charts new seas
November 21st, 2003
Intel charts new seas
For the first time, Intel Corp. has made available its chip-making nanotechnology tools to cancer researchers in the hope that being able to detect tiny defects in silicon chips also will work in human tissue to diagnose and study cancer. Though just preliminary research, Intel's union with the Fred Hutchinson Cancer Research Center in Seattle is part of a voyage toward its future beyond pure-silicon manufacturing. After all, Intel's advanced chips will be commodities within several years, say experts.
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014
The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment: Targeted therapy for hepatocellular carcinoma using nanotechnology August 27th, 2014
Introducing the multi-tasking nanoparticle: Versatile particles offer a wide variety of diagnostic and therapeutic applications August 26th, 2014